Patents by Inventor Walter Ferlin

Walter Ferlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TLR4 Antibodies and Methods of Use Thereof
    Publication number: 20150158946
    Abstract: This invention relates generally to anti-Toll-like Receptor 4 (TLR4 antagonists) including antibodies that specifically bind Toll-like Receptor 4 (TLR-4), to methods of using the anti-TLR4 antagonists as therapeutics and to methods of using the anti-TLR4 antagonists for inhibiting, delaying the progression of, or otherwise ameliorating a symptom of Graft-versus-Host disease (GvHD) and/or improving survival of GvHD subjects and/or transplanted biological materials in subjects.
    Type: Application
    Filed: December 8, 2014
    Publication date: June 11, 2015
    Inventors: Emmanuel Monnet, Limin Shang, Susana Salgado-Pires, Walter Ferlin, Greg Elson
  • Anti-Interferon Gamma Antibodies And Methods Of Use Thereof
    Publication number: 20140186362
    Abstract: The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hIFN?), thereby modulating the interaction between IFN? and its receptor, IFN?-R, and/or modulating the biological activities of IFN?. The invention also relates to the use of such anti-IFN? antibodies in the prevention or treatment of immune-related disorders and in the amelioration of a symptom associated with an immune-related disorder.
    Type: Application
    Filed: October 18, 2013
    Publication date: July 3, 2014
    Inventors: Walter Ferlin, Nicolas Fischer, Greg Elson, Olivier Leger
  • Anti-IL6/IL-6R antibodies
    Patent number: 8337849
    Abstract: This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: December 25, 2012
    Assignee: NovImmune S.A.
    Inventors: Walter Ferlin, Marie Kosco-Vilbois, Greg Elson, Olivier Leger, Florence Guilhot
  • Anti-IL6/IL-6R Antibodies and Methods of Use Thereof
    Publication number: 20120020981
    Abstract: This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
    Type: Application
    Filed: September 7, 2011
    Publication date: January 26, 2012
    Inventors: Walter Ferlin, Marie Kosco-Vilbois, Greg Elson, Olivier Leger, Florence Guilhot
  • Anti-IL-6/IL-6R antibodies and methods of use thereof
    Patent number: 8034344
    Abstract: This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: October 11, 2011
    Assignee: NovImmune S.A.
    Inventors: Walter Ferlin, Marie Kosco-Vilbois, Greg Elson, Olivier Leger, Florence Guilhot
  • Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof
    Publication number: 20110002936
    Abstract: This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
    Type: Application
    Filed: May 13, 2009
    Publication date: January 6, 2011
    Inventors: Walter Ferlin, Marie Kosco-Vilbois, Greg Elson, Olivier Leger, Florence Guilhot
  • Anti-Interferon Gamma Antibodies and Methods of Use Thereof
    Publication number: 20100158922
    Abstract: The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hIFN?), thereby modulating the interaction between IFN? and its receptor, IFN?-R, and/or modulating the biological activities of IFN?. The invention also relates to the use of such anti-IFN? antibodies in the prevention or treatment of immune-related disorders and in the amelioration of a symptom associated with an immune-related disorder.
    Type: Application
    Filed: February 8, 2010
    Publication date: June 24, 2010
    Inventors: Walter Ferlin, Nicolas Fischer, Greg Elson, Olivier Leger
  • Anti-interferon gamma antibodies and methods of use thereof
    Patent number: 7700098
    Abstract: The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hIFN?), thereby modulating the interaction between IFN? and its receptor, IFN?-R, and/or modulating the biological activities of IFN?. The invention also relates to the use of such anti-IFN? antibodies in the prevention or treatment of immune-related disorders and in the amelioration of a symptom associated with an immune-related disorder.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: April 20, 2010
    Assignee: Novimmune SA
    Inventors: Walter Ferlin, Nicolas Fischer, Greg Elson, Olivier Leger
  • Anti-interferon gamma antibodies and methods of use thereof
    Publication number: 20060263363
    Abstract: The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hIFN?), thereby modulating the interaction between IFN? and its receptor, IFN?-R, and/or modulating the biological activities of IFN-?. The invention also relates to the use of such anti-IFN? antibodies in the prevention or treatment of immune-related disorders and in the amelioration of a symptom associated with an immune-related disorder.
    Type: Application
    Filed: January 27, 2006
    Publication date: November 23, 2006
    Inventors: Walter Ferlin, Nicolas Fischer, Greg Elson, Olivier Leger
  • Methods for treating disease with antibodies to CXCR3
    Publication number: 20020039578
    Abstract: The present invention provides antibodies directed against the CXCR3 chemokine receptor protein for use in compositions and methods for the treatment, and prevention of inflammatory diseases and conditions.
    Type: Application
    Filed: March 27, 2001
    Publication date: April 4, 2002
    Inventors: Subhashini Arimilli, Walter Ferlin, Shrikant Deshpande, Simonetta Mocci
  • Chemokine receptor peptide vaccines for treatment and prevention of diabetes
    Publication number: 20010006942
    Abstract: The present invention provides immunogenic oligopeptides derived from the chemokine receptor protein for use in compositions and methods for the treatment, and prevention of inflammatory responses.
    Type: Application
    Filed: January 4, 2001
    Publication date: July 5, 2001
    Inventors: Maureen Howard, Shrikant Deshpande, Walter Ferlin, Subhashini Arimilli
  • Chemokine receptor peptide for inducing an immune response
    Patent number: 6171590
    Abstract: The present invention provides immunogenic oligopeptides derived from the chemokine receptor protein for use in compositions and methods for the treatment, and prevention of inflammatory responses.
    Type: Grant
    Filed: September 30, 1998
    Date of Patent: January 9, 2001
    Assignee: Corixa Corporation
    Inventors: Maureen Howard, Shrikant Deshpande, Walter Ferlin, Subhashini Arimilli